comparemela.com

Latest Breaking News On - Osimertinib tablets - Page 1 : comparemela.com

Market may open flat ahead of RBI policy announcements - The Hindu BusinessLine

Zydus Cadila receives tentative approval from USFDA for Osimertinib Tablets

Zydus Cadila receives tentative approval from USFDA for Osimertinib Tablets
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Zydus Cadila gets tentative USFDA nod to market lung cancer drug

Zydus Cadila gets tentative USFDA nod to market lung cancer drug PTI New Delhi | Updated on June 03, 2021 The drug to be manufactured at the group’s formulation manufacturing facility at SEZ, Ahmedabad Drug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market Osimertinib tablets, used to treat lung cancer. The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Osimertinib tablets in the strengths of 40 mg and 80 mg, Zydus Cadila, part of the Cadila Healthcare group, said in a regulatory filing. Osimertinib is used to treat lung cancer. Osimertinib works by slowing or stopping the growth of cancer cells.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.